News
New publication shows the benefits of the GA-map® testing platform in Diabetes Type 2
OSLO, NORWAY – 23 August 2023: Microbiome DX company Genetic Analysis AS (“GA” or “the Company”) announces that a scientific…
Genetic Analysis receives patent approval in South Africa
OSLO, NORWAY – June 29, 2023: Microbiome DX company Genetic Analysis AS (“GA” or “the Company”) announces that the Company…
Genetic Analysis AS enters an agreement with ELTA90 Group to distribute and launch GA-map® technology in the Balkan region
OSLO, NORWAY – 8 June 2023: Molecular diagnostics specialist, Genetic Analysis AS (“GA”) has entered a distribution agreement with ELTA90…
Genetic Analysis AS: Mandatory notification of trade – Primary Insiders
OSLO, NORWAY – 26 May 2023: Genetic Analysis AS (“GA” or “the Company”) announces that a member of the management…
Genetic Analysis presents at Sedermeradagen 2023 in Stockholm
Genetic Analysis (“GA”) will attend Sedermeradagen next Tuesday, 30th May 2023. Ronny Hermansen, CEO, and Kari Furu, Head of Product…
Interim report January–March 2023
OSLO, NORWAY, May 25, 2023 – Genetic Analysis AS (“GA” or “the Company”) hereby publishes the interim report for the…
Meet us at Worldlab-Euromedlab 2023
We look forward to seeing you at Worldlab-Euromedlab from 22 to 24 May 2023 in Rome. You will find us…
Minutes from the Annual General Meeting 2023 in Genetic Analysis AS
Oslo, Norway, May 11, 2023 – Genetic Analysis AS (the “Company”, Ticker: GEAN) held its Annual General Meeting today, May…
Notice of Annual General Meeting 2023
Notice is hereby served that the annual general meeting of Genetic Analysis AS (the “Company”) will be held on Thursday…
Publication of Genetic Analysis’ 2022 Annual Report
(Oslo, April 20, 2023) Genetic Analysis AS (“GA” or “the Company”) hereby publishes the Annual Report for the financial year…
Genetic Analysis presents at Mangold Insight’s Investor Day
OSLO, NORWAY, March 17, 2023 – Genetic Analysis (“GA”) will attend Mangold Insight’s Investor Day next Wednesday, 22 March 2023….
Year-end report January – December 2022
OSLO, NORWAY, 17 February 2023 – Genetic Analysis AS (“GA” or “the Company”) hereby publishes the year-end report for the…
Genetic Analysis strengthens and future-proofs the organization
OSLO, NORWAY, January 31, 2023 – Molecular diagnostics specialist, Genetic Analysis AS (“GA”) is happy to announce that GA is…
Genetic Analysis’ CTO finalist in the Lyfebulb and Bristol Myers Squibb Innovation Challenge addressing unmet needs in IBD
OSLO, NORWAY, January 27, 2023 – Molecular diagnostics specialist, Genetic Analysis AS (“GA”) is happy to announce that GA’s Chief…
Genetic Analysis AS achieves Thai FDA License for GA-map® Dysbiosis Test in Thailand
OSLO, NORWAY – 19 January 2023: Molecular diagnostics specialist, Genetic Analysis AS (“GA”) are happy to announce that Thailand Food…